Answers are grounded in this paper and cite their sources.
Selective enrichment and sensitive detection of phosphopeptides are of great significance in many bioapplications. In this work, dendritic mesoporous silica nanoparticles modified with polydopamine and chelated Ti 4+ (denoted DMSNs@PDA-Ti 4+ ) were developed to improve the enrichment selectivity of phosphopeptides. The unique central-radial pore structures endowed DMSNs@PDA-Ti 4+ with a high surface area (362 m 2 g –1 ), a large pore volume (1.37 cm 3 g –1 ), and a high amount of chelated Ti 4+ (75 μg mg –1 ). Compared with conventional mesoporous silica-based materials with the same functionalization (denoted mSiO 2 @PDA-Ti 4+ ) and commercial TiO 2, DMSNs@PDA-Ti 4+ showed better selectivity and a lower detection limit (0.2 fmol/μL). Moreover, 2422 unique phosphopeptides were identified from HeLa cell extracts with a high specificity (>95%) enabled by DMSNs@PDA-Ti 4+, better than those in previous reports.
No takes yet. Share an insight, caveat, or question.
Hong et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: